Argenx Says Vyvgart Sales Rose 54% in Third Quarter
Argenx said global sales of its Vyvgart autoimmune drug rose 54% in the third quarter.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.